Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 1;10(5):714.
doi: 10.3390/vaccines10050714.

Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines

Claudia Maria Trombetta  1 , Otfried Kistner  2 , Emanuele Montomoli  1   2   3 , Simonetta Viviani  1 , Serena Marchi  1
Affiliations
Review

Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines

Claudia Maria Trombetta et al. Vaccines (Basel). .

Abstract

Influenza is a vaccine preventable disease and vaccination remains the most effective method of controlling the morbidity and mortality of seasonal influenza, especially with respect to risk groups. To date, three types of influenza vaccines have been licensed: inactivated, live-attenuated, and recombinant haemagglutinin vaccines. Effectiveness studies allow an assessment of the positive effects of influenza vaccines in the field. The effectiveness of current influenza is suboptimal, being estimated as 40% to 60% when the vaccines strains are antigenically well-matched with the circulating viruses. This review focuses on influenza viruses and vaccines and the role of vaccine effectiveness studies for evaluating the benefits of influenza vaccines. Overall, influenza vaccines are effective against morbidity and mortality in all age and risk groups, especially in young children and older adults. However, the effectiveness is dependent on several factors such as the age of vaccinees, the match between the strain included in the vaccine composition and the circulating virus, egg-adaptations occurring during the production process, and the subject's history of previous vaccination.

Keywords: effectiveness; influenza virus; vaccine.

PubMed Disclaimer

Conflict of interest statement

E. Montomoli is an external consultant and Chief Scientific Officer of VisMederi srl and VisMederi Research srl.

References

    1. Centers for Disease Control and Prevention Flu Symptoms & Complications. [(accessed on 31 March 2022)]; Available online: https://www.cdc.gov/flu/symptoms/symptoms.htm.
    1. Centers for Disease Control and Prevention Flu Season. [(accessed on 31 March 2022)]; Available online: https://www.cdc.gov/flu/season/index.html.
    1. Rajaram S., Wojcik R., Moore C., Ortiz de Lejarazu R., de Lusignan S., Montomoli E., Rossi A., Perez-Rubio A., Trilla A., Baldo V., et al. The impact of candidate influenza virus and egg-based manufacture on vaccine effectiveness: Literature review and expert consensus. Vaccine. 2020;38:6047–6056. doi: 10.1016/j.vaccine.2020.06.021. - DOI - PubMed
    1. Morris D.E., Cleary D.W., Clarke S.C. Secondary Bacterial Infections Associated with Influenza Pandemics. Front. Microbiol. 2017;8:1041. doi: 10.3389/fmicb.2017.01041. - DOI - PMC - PubMed
    1. Gupta R.K., George R., Nguyen-Van-Tam J.S. Bacterial pneumonia and pandemic influenza planning. Emerg. Infect. Dis. 2008;14:1187–1192. doi: 10.3201/eid1408.070751. - DOI - PMC - PubMed

LinkOut - more resources